Duration and onset of action of high dose U‐500 regular insulin in severely insulin resistant subjects with type 2 diabetes

AIM: Although regular human U‐500 insulin (U‐500) is frequently used for insulin resistant type 2 diabetics, pharmacokinetic and pharmacodynamic studies in these individuals are lacking. We set out to determine the rate of onset, duration of action and total glucose lowering effect of two doses of U...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Endocrinol Diabetes Metab
Autors principals: Shrestha, Rupendra T., Kumar, Anjali F., Taddese, Abdisa, Khowaja, Ameer A., Moheet, Amir, Olawsky, Evan, Eberly, Lynn E., Seaquist, Elizabeth R.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6354819/
https://ncbi.nlm.nih.gov/pubmed/30815569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/edm2.41
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars